Tags

Type your tag names separated by a space and hit enter

Peak-dose dyskinesia; an acceptable price for mobility in late-stage Parkinson's disease?
Clin Neurophysiol. 2005 Sep; 116(9):1997-8.CN

Authors

No affiliation info available

Pub Type(s)

Comment
Editorial

Language

eng

PubMed ID

16055380

Citation

Wenzelburger, Roland. "Peak-dose Dyskinesia; an Acceptable Price for Mobility in Late-stage Parkinson's Disease?" Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology, vol. 116, no. 9, 2005, pp. 1997-8.
Wenzelburger R. Peak-dose dyskinesia; an acceptable price for mobility in late-stage Parkinson's disease? Clin Neurophysiol. 2005;116(9):1997-8.
Wenzelburger, R. (2005). Peak-dose dyskinesia; an acceptable price for mobility in late-stage Parkinson's disease? Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology, 116(9), 1997-8.
Wenzelburger R. Peak-dose Dyskinesia; an Acceptable Price for Mobility in Late-stage Parkinson's Disease. Clin Neurophysiol. 2005;116(9):1997-8. PubMed PMID: 16055380.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Peak-dose dyskinesia; an acceptable price for mobility in late-stage Parkinson's disease? A1 - Wenzelburger,Roland, PY - 2005/06/09/received PY - 2005/06/11/accepted PY - 2005/8/2/pubmed PY - 2005/11/10/medline PY - 2005/8/2/entrez SP - 1997 EP - 8 JF - Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology JO - Clin Neurophysiol VL - 116 IS - 9 SN - 1388-2457 UR - https://www.unboundmedicine.com/medline/citation/16055380/Peak_dose_dyskinesia DB - PRIME DP - Unbound Medicine ER -